| NIM | I1C022005 |
|---|
| Namamhs | NABILA ZIHAN RIFASHA |
|---|
| Judul Artikel | Evaluasi Potentially Inappropriate Medications (PIMs) Pada Pasien Geriatri Berdasarkan STOPP Criteria di Puskesmas Sokaraja 1 |
|---|
| Abstrak (Bhs. Indonesia) | Pasien geriatri rentan mendapatkan Potentially Inappropriate Medication (PIMs) karena kompleksitas pengobatan yang meningkat seiring dengan perubahan fisiologis, peningkatan komorbiditas, serta kecenderungan polifarmasi. PIMs dapat meningkatkan risiko efek samping obat, rawat inap, dan penurunan kualitas hidup. Salah satu instrument yang dapat digunakan untuk mengidentifikasi PIMs adalah STOPP criteria versi 3. Penelitian ini bertujuan untuk mengetahui gambaran penggunaan obat, persentase kejadian PIMs, dan jenis obat yang termasuk PIMs pada pasien geriatri peserta Prolanis di Puskesmas Sokaraja 1. Penelitian ini merupakan penelitian observasional dengan desain retrospektif menggunakan data rekam medis pasien geriatri Prolanis yang menderita diabetes mellitus dan hipertensi di Puskesmas Sokaraja 1 dan Apotek Karya Sehat periode Oktober 2025-Maret 2026. Sampel penelitian berjumlah 102 pasien yang dipilih menggunakan teknik simple random sampling. Data dianalisis secara deskriptif berdasarkan STOPP criteria versi 3. Sebanyak 62 pasien (60,78%) teridentifikasi mengalami PIMs dengan total 80 kejadian. PIMs paling banyak ditemukan pada sistem endokrin 33 kejadian (41,25%), diikuti sistem renal 20 kejadian (25,00%), sistem kardiovaskular 19 kejadian (23,75%), sistem koagulasi 7 kejadian (8,75%), dan kategori indication of medication 1 kejadian (1,25%). Glimepirid merupakan obat yang paling sering teridentifikasi PIMs, diikuti oleh spironolakton, aspirin, dan metformin. Penelitian ini menunjukkan bahwa lebih dari separuh pasien geriatri teridentifikasi mengalami PIMs. Temuan ini menunjukkan pentingnya evaluasi terapi secara berkala untuk meningkatkan keamanan dan ketepatan penggunaan obat pada pasien geriatri. |
|---|
| Abtrak (Bhs. Inggris) | Geriatric patients are at risk of receiving Potentially Inappropriate Medications (PIMs) due to the increasing complexity of their treatment regimens, which is associated with physiological changes, an increase in comorbidities, and a tendency toward polypharmacy. PIMs can increase the risk of adverse drug reactions, hospitalization, and a decline in quality of life. One of the tools that can be used to identify PIMs is the STOPP criteria version 3. This study aims to determine the profile of medication use, the incidence of PIMs, and the types of medications classified as PIMs among geriatric patients enrolled in the Prolanis program at the Sokaraja 1 Public Health Center. This study is an observational study with a retrospective design using medical record data from Prolanis geriatric patients with type 2 diabetes mellitus and hypertension at the Sokaraja 1 Public Health Center and Karya Sehat Pharmacy from October 2025 to March 2026. The study sample consisted of 102 patients selected using simple random sampling. The data were analyzed descriptively based on the STOPP criteria version 3. A total of 62 patients (60.78%) were identified as having PIMs, with a total of 80 cases. PIMs were most frequently found in the endocrine system with 33 cases (41.25%), followed by the renal system with 20 cases (25.00%), the cardiovascular system with 19 cases (23.75%), the coagulation system with 7 cases (8.75%), and the indication of medication category with 1 case (1.25%). Glimepiride was the drug most frequently associated with PIMs, followed by spironolactone, aspirin, and metformin. This study shows that more than half of geriatric patients were found to have PIMs. These findings highlight the importance of periodic therapy evaluations to improve the safety and appropriateness of medication use in geriatric patients. |
|---|
| Kata kunci | Geriatri, Potentially Inappropriate Medication, STOPP criteria versi 3, Prolanis, Puskesmas Sokaraja 1. |
|---|
| Pembimbing 1 | apt. Tunggul Adi Purwonugroho, M.Sc. |
|---|
| Pembimbing 2 | apt. Dewi Latifatul Ilma, M.Clin.Pharm . |
|---|
| Pembimbing 3 | |
|---|
| Tahun | 2026 |
|---|
| Jumlah Halaman | 10 |
|---|
| Tgl. Entri | 2026-08-28 11:14:56.955406 |
|---|